Adolescents as young as 12 may soon begin rolling up their sleeves to get COVID-19 vaccines in the United States. The U.S. Food and Drug Administration granted emergency use authorization May 10 for Pfizer’s mRNA vaccine to be used in children 12 to 15 years old. It’s “a significant step in the fight against the COVID-19 pandemic,” Acting FDA Commissioner Janet Woodcock said in a news release.
The U.S. Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices will vote on May 12 on a recommendation to extend eligibility for the vaccine to this age group, meaning the shots could be available to them within days.
The move comes about a week after Canada became the first country to authorize Pfizer’s COVID-19 vaccine for that age group. Meanwhile, Moderna announced in a news release May 6 that early data from its trial in adolescents ages 12 and up indicate that the vaccine has 96 percent efficacy in that age group. The company says it is working with regulators to extend use of its vaccine to teens and adolescents, perhaps by the end of May.
https://www.sciencenews.org/article/pfizer-covid-vaccine-kids-12-to-15-years-old-fda
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου